CH651933A5 - Reagenz zur bestimmung von aldolase vom humanmuskeltyp. - Google Patents
Reagenz zur bestimmung von aldolase vom humanmuskeltyp. Download PDFInfo
- Publication number
- CH651933A5 CH651933A5 CH1389/81A CH138981A CH651933A5 CH 651933 A5 CH651933 A5 CH 651933A5 CH 1389/81 A CH1389/81 A CH 1389/81A CH 138981 A CH138981 A CH 138981A CH 651933 A5 CH651933 A5 CH 651933A5
- Authority
- CH
- Switzerland
- Prior art keywords
- aldolase
- antibody
- human muscle
- solution
- muscle type
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 8
- 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 title description 16
- 238000000034 method Methods 0.000 claims description 37
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 27
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 26
- 210000003205 muscle Anatomy 0.000 claims description 21
- 239000007790 solid phase Substances 0.000 claims description 10
- 230000002285 radioactive effect Effects 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 239000000243 solution Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 11
- 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 101710123627 Fructose-bisphosphate aldolase A Proteins 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108010044467 Isoenzymes Proteins 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010029719 Nonspecific reaction Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000029052 metamorphosis Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061968 Gastric neoplasm Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 201000009019 intestinal benign neoplasm Diseases 0.000 description 1
- ZKLLSNQJRLJIGT-UYFOZJQFSA-N keto-D-fructose 1-phosphate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)COP(O)(O)=O ZKLLSNQJRLJIGT-UYFOZJQFSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2799680A JPS56125667A (en) | 1980-03-07 | 1980-03-07 | Reagent for measurement and measuring method for human muscle type aldolase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH651933A5 true CH651933A5 (de) | 1985-10-15 |
Family
ID=12236425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1389/81A CH651933A5 (de) | 1980-03-07 | 1981-03-02 | Reagenz zur bestimmung von aldolase vom humanmuskeltyp. |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS56125667A (fr) |
| BE (1) | BE887828A (fr) |
| CA (1) | CA1141291A (fr) |
| CH (1) | CH651933A5 (fr) |
| DE (1) | DE3107268A1 (fr) |
| FR (1) | FR2477573A1 (fr) |
| GB (1) | GB2071318B (fr) |
| IT (1) | IT1136853B (fr) |
| NL (1) | NL8101068A (fr) |
| SE (1) | SE8101404L (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649039A (en) * | 1984-07-03 | 1987-03-10 | E. I. Du Pont De Nemours And Company | Radiolabeling of methionine-containing proteins and peptides |
| JPH0672893B2 (ja) * | 1985-08-16 | 1994-09-14 | 富士薬品工業株式会社 | ヒト血中のヒトプロリルヒドロキシラーゼの放射性免疫学的測定法による定量法 |
| WO2006067792A2 (fr) * | 2004-12-22 | 2006-06-29 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Autoantigenes de l'aldolase utiles pour le diagnostic et le traitement de la maladie d'alzheimer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5648894A (en) * | 1979-09-25 | 1981-05-02 | Eisai Co Ltd | Reagent for measuring human muscular aldolase and its determination |
-
1980
- 1980-03-07 JP JP2799680A patent/JPS56125667A/ja active Pending
-
1981
- 1981-02-26 DE DE19813107268 patent/DE3107268A1/de not_active Withdrawn
- 1981-03-02 CH CH1389/81A patent/CH651933A5/de not_active IP Right Cessation
- 1981-03-03 FR FR8104174A patent/FR2477573A1/fr active Pending
- 1981-03-04 IT IT20117/81A patent/IT1136853B/it active
- 1981-03-04 SE SE8101404A patent/SE8101404L/ unknown
- 1981-03-05 NL NL8101068A patent/NL8101068A/nl not_active Application Discontinuation
- 1981-03-06 CA CA000372438A patent/CA1141291A/fr not_active Expired
- 1981-03-06 GB GB8107059A patent/GB2071318B/en not_active Expired
- 1981-03-06 BE BE0/204036A patent/BE887828A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56125667A (en) | 1981-10-02 |
| IT8120117A0 (it) | 1981-03-04 |
| NL8101068A (nl) | 1981-10-01 |
| GB2071318A (en) | 1981-09-16 |
| DE3107268A1 (de) | 1982-01-07 |
| IT1136853B (it) | 1986-09-03 |
| FR2477573A1 (fr) | 1981-09-11 |
| GB2071318B (en) | 1983-08-24 |
| SE8101404L (sv) | 1981-09-08 |
| BE887828A (fr) | 1981-07-01 |
| CA1141291A (fr) | 1983-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3650513T2 (de) | Verzögerter immunologischer Test in fester Phase | |
| DE69936916T2 (de) | Liganden-bindetest und kit mit einer abtrennzone für störende probenkomponenten | |
| DE2743444C3 (de) | Immunchemisches Meßverfahren und Reagens zu seiner Durchführung | |
| DE4037724C2 (de) | Vorrichtungen für Immunoassays und deren Materialien | |
| DE68920140T2 (de) | Gerät und verfahren zur schnellen qualitativen und quantitativen bestimmung der anwesenheit eines reaktiven liganden in einer flüssigkeit. | |
| DE2448411A1 (de) | Verfahren und vorrichtung zur bestimmung von substanzen mit einer gegenseitigen spezifischen bindungsaffinitaet | |
| DE2206103A1 (de) | Verfahren zum Nachweisen und Bestimmen einer Komponente der Reaktion zwischen spezifisch bindenden Proteinen und den Substanzen, die von diesen Proteinen spezifisch gebunden werden | |
| CH645465A5 (de) | Immunbiologisches verfahren zur quantitativen bestimmung von haptenen und testausruestung zur durchfuehrung des verfahrens. | |
| EP0544869B1 (fr) | Procede immunologique de depistage d'anticorps dans des liquides biologiques et kit de mise en oeuvre du procede | |
| CH651138A5 (de) | Immunometrische und inhibierungsassays unter verwendung von monoclonalen antikoerpern. | |
| DE3433652A1 (de) | Immunchemisches messverfahren fuer haptene und proteine | |
| EP0291086B1 (fr) | Procédé pour déterminer un anticorps dans des liquides du corps humain | |
| DE4328070C1 (de) | Verfahren zur Bestimmung eines Analyten in einem Volumen einer flüssigen Probe sowie seine Anwendung zur Bestimmung von anti-TSH-Rezeptor-Autoantikörpern in einem Patientenserum | |
| DE2952478A1 (de) | Verfahren und mittel zur immunologischen bestimmung von enzymen | |
| DE2900546C3 (de) | Verfahren zum Standardisieren einer markierten Bindungskomponente, welche in einem spezifischen Bindungstest-Verfahren mit einem Liganden reagiert, gegen einen Liganden-Referenzstandard und Verwendung der standardisierten markierten Bindungskomponente in spezifischen Bindungstest-Verfahren | |
| DE69304528T2 (de) | Verfahren zur bestimmung der menge eines schilddrüsenhormon-liganden in einer biologischen flüssigkeit und satz zur durchführung dieses verfahrens | |
| DE3685818T2 (de) | Immunkomplextestverfahren. | |
| EP0366092B1 (fr) | Procédé pour déterminer des anticorps antigène- et classes-spécifiques et réactif pour ce procédé | |
| CH651933A5 (de) | Reagenz zur bestimmung von aldolase vom humanmuskeltyp. | |
| EP0809805B2 (fr) | Utilisation d'autoanticorps anti-htg polyclonaux humains comme reactifs pour le diagnostic clinique d'affections auto-immunes de la thyroide et jeu de reactifs servant a detecter les autoanticorps anti-htg dans les serums de patients | |
| EP0249877B1 (fr) | Procédé pour la préparation d'un support immunoréactif pour l'analyse immunologique hétérogène | |
| EP0303284B1 (fr) | Procédé immunologique pour déterminer des substances hapténiques libres | |
| DE2641713A1 (de) | Immunfluoreszenz-nachweisverfahren in fester phase | |
| DE69715014T2 (de) | Glycolipid-komplexe und ihre anwendung. | |
| DE3036184A1 (de) | Reagenz und verfahren zur bestimmung von human-muskeltyp-aldolase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |